NUS · Nu Skin Enterprises, Inc. · Financials
Market Cap
$236.08M
Shares
48.68M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$1.49B
-14.3%
FY2025
Net Income
$160.2M
+209.3%
FY2025
Gross Margin
69.45%
+1.2pp
FY2025
Operating Margin
4.43%
+13.2pp
FY2025
Diluted EPS
$3.18
+207.8%
FY2025
Operating Cash Flow
$80.29M
-28.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.28B – $1.35B | $1.38B | $1.49B | $1.73B | $1.97B | $2.23B | $2.7BG | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | $2.57B | $3.18B | $2.13B | $1.72B | $1.54B | $1.33B | — | |
| — | $423.76M | $453.76M | $550.23M | $611.85M | $630.92M | $675.22M | $658.03M | $581.42M | $634.14M | $502.08M | $500.46M | $489.51M | $478.43M | $505.81M | $353.15M | $322.62M | $272.43M | $243.65M | $228.6M | |
| — | $951.49M | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | $2.09B | $2.67B | $1.78B | $1.4B | $1.26B | $1.09B | $1.02B | |
| — | — | 69.45% | 68.23% | 68.93% | 71.65% | 74.95% | 74.51% | 75.98% | 76.33% | 77.97% | 77.33% | 78.22% | 81.38% | 84.08% | 83.44% | 81.24% | 82.28% | 81.7% | — | |
| — | — | $10.8M | $13M | $22.6M | $23.3M | $27.2M | $23.3M | $30.1M | $23M | $22M | $24.3M | $20.1M | $18.9M | $18M | $14.9M | $13.6M | $12.4M | $10.4M | — | |
| — | $401.6M | $432.14M | $479.04M | $546.86M | $555.77M | $654.43M | $636.47M | $615.97M | $662.3M | $564.51M | $554.15M | $561.46M | $622.3M | $640.03M | $505.45M | $436.18M | $401.42M | $369.37M | $360.47M | |
| — | — | $7.1M | $12.3M | $11.9M | $9.7M | $11.7M | $9.8M | $13.4M | $18.3M | $8.1M | $8.4M | $8.6M | $8.4M | $7.8M | $7.9M | $7.1M | — | — | — | |
| — | $50M | $52.26M | $69.81M | $70.92M | $72.51M | $76.32M | $73.99M | $76.65M | $83M | $71.56M | $72.4M | $71.37M | $54.92M | $34.92M | $33.41M | $32.85M | $29.62M | $28.56M | $30.39M | |
| — | — | — | — | — | — | — | — | $22.1M | $22.1M | — | — | — | — | — | — | $0 | $0 | $10.72M | $0 | |
| — | $961.9M | $965.64M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.8B | $1.5B | $1.48B | $1.51B | $1.74B | $2.12B | $1.44B | $1.16B | $1.05B | $939.7M | $893.62M | |
| — | -$10.41M | $65.76M | -$151.59M | $48.27M | $110.85M | $233.99M | $257.56M | $267.43M | $240.86M | $274.48M | $231.1M | $244.7M | $352.19M | $554.11M | $340.84M | $233.74M | $217.06M | $147.71M | $125.43M | |
| — | — | 4.43% | -8.75% | 2.45% | 4.98% | 8.68% | 9.98% | 11.05% | 8.99% | 12.04% | 10.47% | 10.89% | 13.71% | 17.44% | 15.99% | 13.59% | 14.12% | 11.1% | — | |
| — | $39.6M | $118.02M | -$81.78M | $119.19M | $183.35M | $310.31M | $331.56M | $344.08M | $323.86M | $346.05M | $303.5M | $316.07M | $407.11M | $589.04M | $374.26M | $266.59M | $246.68M | $176.27M | $155.82M | |
| — | $15.71M | $13.95M | $26.41M | $25.6M | $13.5M | $11M | $13.1M | $19.2M | $21.8M | $22.2M | $15.6M | $7.9M | $5.7M | $3M | $5.2M | $4.8M | $5.8M | $6.9M | — | |
| — | -$273K | -$31.78M | $2.94M | $3.87M | -$8.38M | -$1.53M | -$1.33M | -$12.25M | -$21.19M | -$8.92M | -$18.27M | -$32.74M | -$53.68M | $2.83M | $4.4M | -$6.97M | -$9.45M | -$6.59M | -$24.78M | |
| — | — | — | — | — | — | — | $0 | $0 | $456K | $1.05M | $0 | $0 | — | — | — | — | — | — | — | |
| — | -$26.39M | $196.2M | -$175.05M | $26.58M | $88.97M | $232.46M | $256.23M | $255.17M | $219.67M | $265.57M | $212.84M | $211.96M | $298.51M | $556.94M | $345.24M | $226.77M | $207.61M | $141.12M | $100.65M | |
| — | $190M | $35.99M | -$28.46M | $17.98M | -$15.81M | $85.19M | $64.88M | $81.62M | $97.78M | $136.13M | $69.75M | $78.91M | $109.33M | $192.05M | $123.6M | $73.44M | $71.56M | $51.28M | $35.31M | |
| — | -$216.39M | $160.2M | -$146.59M | $8.6M | $104.78M | $147.27M | $191.36M | $173.55M | $121.89M | $129.44M | $143.09M | $133.05M | $189.18M | $364.89M | $221.65M | $153.33M | $136.05M | $89.85M | $65.35M | |
| — | — | 10.79% | -8.46% | 0.44% | 4.71% | 5.46% | 7.41% | 7.17% | 4.55% | 5.68% | 6.48% | 5.92% | 7.36% | 11.49% | 10.39% | 8.92% | 8.85% | 6.75% | — | |
| — | -$220.49M | $168.86M | -$171.35M | -$4.9M | $92.17M | $138.14M | $211.88M | $168.2M | $108.27M | $147.24M | $130.23M | $113.3M | $183.88M | $370.48M | $232.39M | $149.3M | $145.65M | $91.77M | $63.05M | |
| USD/shares | — | -$4.44 | $3.25 | -$2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | $3.20 | $6.23 | $3.66 | $2.47 | $2.18 | $1.42 | $1.03 |
| USD/shares | — | -$4.49 | $3.18 | -$2.95 | $0.17 | $2.07 | $2.86G | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | $3.11 | $5.94 | $3.52 | $2.38 | $2.11 | $1.40 | $1.02 |
| shares | — | — | 49.29M | 49.66M | 49.71M | 50M | 50.19M | 52.3M | 55.52M | 55.17M | 52.81M | 55.41M | 58M | 59.07M | 58.61M | 60.6M | 62.07M | 62.37M | 63.33M | 63.51M |
| shares | — | — | 50.3M | 49.66M | 49.86M | 50.53M | 51.43M | 52.77M | 55.93M | 56.48M | 54.85M | 56.1M | 59.06M | 60.89M | 61.45M | 63.03M | 64.55M | 64.55M | 64.3M | 64.13M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.42B in buybacks, $1.06B in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.19×
Peer median 0.77×
EV/EBIT
—
Peer median 32.38×
P/E (TTM)
—
Peer medians compare against the 11 similar-size Household & Personal Products companies (of 27 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Americas Segment | $282,975,000 | $322,516,000 | $398,222,000 | $508,537,000 | $547,755,000 | $453,022,000 | $304,422,000 | — |
| Southeast Asia Pacific Segment | $209,802,000 | $244,846,000 | $267,206,000 | $344,411,000 | $336,651,000 | $361,627,000 | $346,276,000 | — |
| Manufacturing Segment | $205,788,000 | $201,430,000 | $181,395,000 | $149,458,000 | $172,120,000 | $149,339,000 | $121,917,000 | $90,606,000 |
| Mainland China Segment | $195,553,000 | $235,235,000 | $298,079,000 | $360,389,000 | $568,774,000 | $625,538,000 | $722,526,000 | $886,472,000 |
| Japan Segment | $174,364,000 | $181,557,000 | $207,833,000 | $224,896,000 | $266,216,000 | $273,681,000 | $260,039,000 | $254,939,000 |
| Europe And Africa Segment | $150,151,000 | $164,164,000 | $192,352,000 | $204,275,000 | $283,200,000 | — | — | — |
| South Korea Segment | $130,216,000 | $163,706,000 | $236,099,000 | $268,707,000 | $354,252,000 | $326,478,000 | $329,978,000 | $373,357,000 |
| Hong Kong Taiwan Segment | $117,378,000 | $130,610,000 | $153,589,000 | $157,197,000 | $162,611,000 | $161,117,000 | $166,335,000 | $185,893,000 |
| Rhyz Other Segment | $17,794,000 | $85,188,000 | $35,214,000 | $3,830,000 | $437,000 | $0 | $0 | — |
| Americas Pacific Segment | — | — | — | — | — | $511,941,000 | $349,078,000 | $385,034,000 |
| Emea Segment | — | — | — | — | $283,200,000 | $230,246,000 | $167,165,000 | $182,394,000 |
| GrowTech Segment | — | — | — | — | $2,104,000 | $903,000 | $137,000 | $0 |
| Nu Skin | — | — | — | — | $2,523,112,000 | — | — | — |
| Nu Skin Segment | — | — | — | — | $2,523,112,000 | $2,432,595,000 | $2,298,362,000 | $2,588,402,000 |
| Rhyz Investments Segment | — | — | — | — | $172,557,000 | $149,339,000 | $122,054,000 | — |
| Rhyz | — | — | — | — | $172,557,000 | — | — | — |
| Southeast Asia Segment | — | — | — | — | — | $302,708,000 | $301,620,000 | $316,890,000 |
| Corporate | — | — | — | — | $3,653,000 | $886,000 | $1,621,000 | $3,423,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Wellness | $689,062,000 | $757,217,000 | $886,093,000 | $992,338,000 | $1,062,549,000 | $922,553,000 | $863,125,000 | $921,328,000 |
| Beauty | $568,113,000 | $681,765,000 | $858,625,000 | $1,069,714,000 | $1,442,659,000 | $1,491,803,000 | $1,423,485,000 | — |
| Other Product Lines | $227,984,000 | $293,102,000 | $224,413,000 | $163,607,000 | $190,461,000 | $167,578,000 | $133,806,000 | $97,943,000 |
| Devices and Related Consumables | — | — | — | — | — | — | $618,000,000 | — |
| Personal Care | — | — | — | — | — | — | $1,423,485,000 | $1,659,737,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Americas Segment | $60,488,000 | $67,717,000 | $78,943,000 | $97,298,000 | $103,067,000 | $86,386,000 | $52,135,000 | — |
| Japan Segment | $48,972,000 | $50,798,000 | $54,076,000 | $51,620,000 | $65,167,000 | $68,027,000 | $61,081,000 | $56,676,000 |
| Southeast Asia Pacific Segment | $46,775,000 | $45,230,000 | $47,743,000 | $75,902,000 | $72,774,000 | $87,753,000 | $90,666,000 | — |
| Mainland China Segment | $45,555,000 | $46,090,000 | $62,259,000 | $72,362,000 | $151,645,000 | $181,024,000 | $191,570,000 | $253,598,000 |
| South Korea Segment | $37,459,000 | $50,746,000 | $74,091,000 | $78,811,000 | $110,328,000 | $100,933,000 | $99,892,000 | $107,215,000 |
| Hong Kong Taiwan Segment | $37,172,000 | $34,689,000 | $40,582,000 | $32,584,000 | $34,065,000 | $33,466,000 | $33,569,000 | $33,392,000 |
| Europe And Africa Segment | $22,633,000 | $21,009,000 | $18,592,000 | $15,959,000 | $34,846,000 | — | — | — |
| Manufacturing Segment | $7,813,000 | $1,460,000 | $12,321,000 | $3,570,000 | $18,346,000 | $21,168,000 | $15,693,000 | $7,754,000 |
| Rhyz Other Segment | -$30,593,000 | -$45,809,000 | -$20,564,000 | -$6,180,000 | -$1,813,000 | $0 | $0 | — |
| Americas Pacific Segment | — | — | — | — | — | $91,627,000 | $57,090,000 | $52,433,000 |
| Emea Segment | — | — | — | $21,446,000 | $41,988,000 | $24,078,000 | $10,195,000 | $14,773,000 |
| GrowTech Segment | — | — | — | — | -$83,907,000 | -$22,430,000 | -$19,509,000 | -$9,228,000 |
| Nu Skin | — | — | $376,286,000 | $424,536,000 | $571,892,000 | — | — | — |
| Nu Skin Segment | — | — | — | $462,190,000 | $610,552,000 | $581,667,000 | $539,108,000 | $596,685,000 |
| Rhyz Investments Segment | — | — | — | -$2,610,000 | $16,533,000 | $21,168,000 | -$3,816,000 | — |
| Rhyz | — | — | -$8,243,000 | -$2,610,000 | $16,533,000 | — | — | — |
| Southeast Asia Segment | — | — | — | — | — | $75,538,000 | $82,455,000 | $78,598,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Americas Segment | 21.4% | 21% | 19.8% | 19.1% | 18.8% | 19.1% | 17.1% | — |
| Southeast Asia Pacific Segment | 22.3% | 18.5% | 17.9% | 22% | 21.6% | 24.3% | 26.2% | — |
| Manufacturing Segment | 3.8% | 0.7% | 6.8% | 2.4% | 10.7% | 14.2% | 12.9% | 8.6% |
| Mainland China Segment | 23.3% | 19.6% | 20.9% | 20.1% | 26.7% | 28.9% | 26.5% | 28.6% |
| Japan Segment | 28.1% | 28% | 26% | 23% | 24.5% | 24.9% | 23.5% | 22.2% |
| Europe And Africa Segment | 15.1% | 12.8% | 9.7% | 7.8% | 12.3% | — | — | — |
| South Korea Segment | 28.8% | 31% | 31.4% | 29.3% | 31.1% | 30.9% | 30.3% | 28.7% |
| Hong Kong Taiwan Segment | 31.7% | 26.6% | 26.4% | 20.7% | 20.9% | 20.8% | 20.2% | 18% |
| Rhyz Other Segment | -171.9% | -53.8% | -58.4% | -161.4% | -414.9% | — | — | — |
| Americas Pacific Segment | — | — | — | — | — | 17.9% | 16.4% | 13.6% |
| Emea Segment | — | — | — | — | 14.8% | 10.5% | 6.1% | 8.1% |
| GrowTech Segment | — | — | — | — | -3988% | -2483.9% | -14240.1% | — |
| Nu Skin | — | — | — | — | 22.7% | — | — | — |
| Nu Skin Segment | — | — | — | — | 24.2% | 23.9% | 23.5% | 23.1% |
| Rhyz Investments Segment | — | — | — | — | 9.6% | 14.2% | -3.1% | — |
| Rhyz | — | — | — | — | 9.6% | — | — | — |
| Southeast Asia Segment | — | — | — | — | — | 25% | 27.3% | 24.8% |
Key facts
CIK
1021561
CUSIP
67018T105
13F (30d)
54 filings
54 filers
Visit website
Investor relations